After years of struggling with hurdles such as generic competition and significantly lower-than-expected sales of its top meds, Acorda Therapeutics is hanging up the gloves with a $185 million ...

Shares of Acorda Therapeutics ACOR fell late Monday after the company said it had filed for bankruptcy protection. The stock was down 38%, to $8.40, in late trading, following a 2% rise at Monday ...

PEARL RIVER - Acorda Therapeutics, which manufactures key medications used by MS and Parkinson's patients, will lay off all its 97 employees in June, according to a notice filed with the New York ...

PEARL RIVER, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it will no longer hold its fourth quarter and year end 2023 earnings conference call originally ...

PEARL RIVER, N.Y., April 15, 2024--(BUSINESS WIRE)--Acorda Therapeutics, Inc. today announced that its common stock is no longer listed on the Nasdaq Stock Market. The delisting is a result of the ...

Place the bread in a high-sided mixing bowl and, once the stock is finished, strain the stock over the bread. Mix it a little until the bread is fully soaked - about 5 to 15 minutes. Now it's time ...

Pearl River's Acorda Therapeutics, a developer of therapies for neurological disorders such as Parkinson's disease, has announced its closure. This decision will directly impact 97 employees ...

Acorda Therapeutics (NASDAQ:ACOR) stock is falling hard on Tuesday after the biopharmaceutical company signed a stalking horse asset purchase agreement with Merz Therapeutics. This agreement will ...

This press release includes forward-looking statements. All statements, other than statements of historical facts, regarding management's expectations, beliefs, goals, plans or prospects should be ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

PEARL RIVER, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced that Nasdaq Stock Market ("Nasdaq") today notified the Company that it will suspend trading in and delist the ...